Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials.
<h4>Background</h4>Amifostine is the most clinical used chemical radioprotector, but its effect in patients treated with radiation is not consistent.<h4>Methods</h4>By searching Medline, CENTRAL, EMBASE, ASCO, ESMO, and CNKI databases, the published randomized controlled tria...
Main Authors: | Jundong Gu, Siwei Zhu, Xuebing Li, Hua Wu, Yang Li, Feng Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0095968&type=printable |
Similar Items
-
Amifostine before radiotherapy: A rare cause of SJS-TEN overlap
by: Sujata Sengupta
Published: (2015-01-01) -
Risk of CVD Following Radiotherapy for Head and Neck Cancer: An Updated Systematic Review and Meta-Analysis
by: Ping-Yi Lin, et al.
Published: (2022-06-01) -
A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
by: Feng Hua, et al.
Published: (2014-01-01) -
Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)
by: Margot Baudelet, et al.
Published: (2020-03-01) -
Experience of radiotherapy in head and neck
by: Dhiancarlo Rocha MACEDO, et al.
Published: (2019-06-01)